Newman et al. [19] have reported that FGFBP2 variant is highly prevalent in circulating CD4+cytotoxic T cells (CD4+Tc) in a family rather than in sporadic IgG4-RD patients. The gene discussed is CD4; the disease is immunoglobulin G4-related sclerosing disease.